KKR Genetic Disorder, 10% Owner: BridgeBio Pharma BBIO Sell · Filed 24/09/17

Trade details

Type: Insider sale
Amount: $149,350,000
Shares · price: 5,800,000 sh · $25.75 a share
Held after: 25,260,971 sh
Stock: BridgeBio Pharma BBIO
Person: KKR Genetic Disorder10% Owner
Trade date: 24/09/13
Filed: 24/09/17
Days to filing: 4 days

Sold 18.7% of holdings

Share of holding sold: 18.7%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 24/08/14~24/10/13

KKR Genetic Disorder's recent trades

KKR Genetic Disorder10% Owner
SellBridgeBio Pharma
Sell
BridgeBio Pharma
BBIO
$205.2M
6,000,000 sh
$205.2M
Filed 25/05/14
Traded 25/05/12
KKR Genetic Disorder10% Owner
Planned saleBridgeBio Pharma
Planned sale
BridgeBio Pharma
BBIO
$214.1M
6,000,000 sh
$214.1M
Filed 25/05/12
Traded 25/05/12
KKR Genetic Disorder10% Owner
SellBridgeBio Pharma
Sell
BridgeBio Pharma
BBIO
$197.8M
6,000,000 sh
$197.8M
Filed 25/03/07
Traded 25/03/05
KKR Genetic DisorderAffiliate
Planned saleBridgeBio Pharma
Planned sale
BridgeBio Pharma
BBIO
$209.8M
6,000,000 sh
$209.8M
Filed 25/03/05
Traded 25/03/05